The Peptide Encyclopedia
Your comprehensive guide to therapeutic peptides. Explore mechanisms, clinical evidence, FDA status, and find clinics that offer them. 117 peptides covered and growing.
Your comprehensive guide to therapeutic peptides. Explore mechanisms, clinical evidence, FDA status, and find clinics that offer them. 117 peptides covered and growing.
Showing 34 peptides in Hormone Optimization
Growth Hormone Releasing Hormone Analog
Stabilized GHRH analog, FDA-approved as Egrifta for excess abdominal fat in adults with HIV lipodystrophy.
Growth Hormone Secretagogue
A research peptide blend formulated to investigate growth hormone axis modulation through combined GHRH and ghrelin receptor pathways.
Peptide Blend
A compounded blend combining ipamorelin (ghrelin receptor agonist) with tesamorelin (GHRH analogue) for synergistic GH secretion with tesamorelin's additional visceral fat-reducing properties.
Peptide Blend
A triple-peptide compounded blend combining AOD-9604 (fat-mobilizing GH fragment) with CJC-1295 and ipamorelin for comprehensive GH-axis optimization with targeted lipolysis.
Growth Hormone Releasing Hormone
GHRH analog for growth hormone deficiency, formerly FDA-approved as Geref and now compounded by prescription.
Growth Hormone Secretagogue
Combination growth hormone secretagogue therapy.
Growth Hormone
HGH 191AA refers to recombinant human growth hormone (somatropin) with the full 191 amino acid sequence. It is FDA-approved under multiple brand names for growth hormone deficiency, Turner syndrome, and other specific indications.
Growth Hormone Releasing Peptide
A selective growth hormone-releasing peptide with minimal side effects.
Growth Hormone Releasing Hormone Analog
A growth hormone-releasing hormone analog that increases GH and IGF-1 levels.
Growth Hormone Releasing Peptide
Potent GHRP that stimulates GH secretion for muscle recovery and anti-aging.
Growth Hormone Releasing Peptide
Growth hormone-releasing peptide that stimulates appetite and GH secretion.
Peptide Blend
Adamax is a branded compounded peptide blend typically combining CJC-1295 DAC, Ipamorelin, and BPC-157, formulated to simultaneously stimulate growth hormone secretion, promote tissue repair, and support recovery — often available as a single reconstitution vial.
Russian Bioregulator Peptide
Testagen is a synthetic tetrapeptide bioregulator (Lys-Glu-Asp-Gly, KEDG) from Khavinson's group in St. Petersburg, marketed for male reproductive health. Published research on KEDG covers DNA and histone binding and a few animal studies; no study has tested it on the testes, testosterone or sperm in people.
Peptide Blend
A compounded blend of CJC-1295 (GHRH analogue) and GHRP-2 (ghrelin receptor agonist) for synergistic growth hormone stimulation through complementary receptor pathways.
Growth Hormone Secretagogue
CJC-1295 (no DAC) and Ipamorelin is a research peptide blend combining two mechanistically distinct secretagogues that act synergistically on the growth hormone axis.
Growth Hormone Secretagogue
MK-677 (ibutamoren) is an oral, non-peptide growth hormone secretagogue developed by Merck. Human trials used 25 mg once daily; it was never FDA approved.
Growth Hormone Secretagogue
GHRP-2 is a synthetic hexapeptide that functions as a potent growth hormone secretagogue.
Peptide Blend
The most widely used compounded GH peptide combination, pairing modified GRF 1-29 (CJC-1295 without DAC) with ipamorelin for a clean, pulsatile GH release that mimics natural secretory patterns.
IGF-1 Analogue
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified 83-amino acid analogue of IGF-1 with an N-terminal arginine extension and Glu3→Arg3 substitution, conferring a half-life of approximately 20–30 hours versus 12–15 minutes for native IGF-1.
IGF-1 Splice Variant
Mechano Growth Factor (MGF) is an alternatively spliced form of the IGF-1 gene expressed locally in muscle tissue following mechanical stretch or damage, promoting satellite cell activation and muscle repair.
Follistatin 315 is a research peptide isoform of the follistatin protein that binds and neutralizes activins and myostatin.
Follistatin is a multifunctional glycoprotein studied for its role in growth factor signaling networks.
Follistatin 344 is a research peptide variant known to bind myostatin and activin-A, modulating TGF-β signaling.
Gonadotropin
Human chorionic gonadotropin (hCG) is a placental glycoprotein hormone that acts like luteinizing hormone. It is FDA-approved for prepubertal cryptorchidism, selected male hypogonadotropic hypogonadism and ovulation induction; clinics also use it off-label alongside testosterone therapy and after anabolic steroid use.
Neuropeptide
Neuropeptide involved in reproductive hormone regulation and sexual health.
Gonadotropin Mixture
Human menopausal gonadotropin (HMG) is a purified gonadotropin preparation derived from the urine of postmenopausal women, containing both FSH and LH activity. It is used primarily for fertility induction and restoration of spermatogenesis.
Neuropeptide
Oxytocin is a nine-amino-acid hormone made in the hypothalamus that drives uterine contractions and milk let-down and also acts in the brain. It is FDA-approved as Pitocin for obstetric use; compounded nasal and subcutaneous forms for anxiety, social or sexual goals are off-label.
Gonadotropin-Releasing Hormone
Gonadorelin is a research peptide corresponding to the natural gonadotropin-releasing hormone (GnRH).
Growth Hormone Secretagogue
GHRH is a 44-amino acid hypothalamic research peptide that stimulates growth hormone release.
Hypothalamic regulatory peptide
Thyrotropin releasing hormone (TRH or Protirelin) is a research peptide that modulates pituitary secretion of thyrotropin (TSH) and prolactin.
Gonadotropin-Releasing Hormone Analog
Triptorelin is a synthetic decapeptide analog of gonadotropin-releasing hormone (GnRH).
Bioregulator
Pancragen is the synthetic tetrapeptide Lys-Glu-Asp-Trp (KEDW, usually amidated) developed by Khavinson's group as a pancreas "bioregulator." It was designed as a copy of a fragment shared by insulin-releasing hormones and has been studied in pancreatic cell cultures, diabetic rats, old monkeys and two small human studies.
Activin Receptor Fusion Protein
ACE-031 (ramatercept) is a myostatin-trapping protein from Acceleron. Its Duchenne trial was stopped in 2011 for nosebleeds and dilated blood vessels.
Follistatin Analog
FLGR-242 is a brand-name follistatin product sold as a modified Follistatin 344 with an albumin-binding tail. No study of it has been published.